Association of Pretreatment Circulating Tumor Tissue–Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal Cancer
Eleni M. Rettig(Dana-Farber Cancer Institute), Glenn J. Hanna(Dana-Farber Cancer Institute), Vickie Y. Jo(Brigham and Women's Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital), Laura A. Goguen(Brigham and Women's Hospital), Annette A. Wang(Harvard University), Donald J. Annino(Harvard University), Ngoc‐Anh Tran(Brigham and Women's Hospital), Kartik Sehgal(Beth Israel Deaconess Medical Center), Ravindra Uppaluri(Brigham and Women's Hospital), Roy B. Tishler(Dana-Farber Cancer Institute), Danielle N. Margalit(Harvard University), Robert I. Haddad(Georgetown University), Evan Carey(Dana-Farber Cancer Institute), Jeffrey P. Guenette(Brigham and Women's Hospital), Tanujit Dey(Brigham and Women's Hospital), Rosh K.V. Sethi(Brigham and Women's Hospital)
Cited by 70
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926